Canadian-based drug company Cardiome Pharma Corp. (NASDAQ: CRME) announced this morning that Merck & Co. Inc. (NYSE: MRK) has cancelled further development of an oral version of a Cardiome drug being reviewed as a…
St. Jude Medical Inc. (NYSE: STJ) has settled a royalty dispute with medical device maker Kensey Nash Corp. (NASDAQ: KNSY) over a device that St. Jude licensed from Kensey in 1999. The settlement amount…
Drug maker Ampio Pharmaceuticals Inc. (NASDAQ: AMPE) reported this morning that clinical trials of the company’s Optina treatment for a type of macular disease have been successful: A preliminary assessment, of the primary end…
Respiratory drug maker Discovery Laboratories Inc. (NASDAQ: DSCO) priced a secondary offering of slightly more than 16 million shares this morning, and the stock is getting pummeled as a result. Discovery priced the shares…
Cancer therapy developer OncoGenex Pharmaceuticals Inc. (NASDAQ: OGXI) has priced a secondary offering of 4.165 million common shares at $12.00/share, a discount of 31% to yesterday’s closing price of $17.43. Needless to say the…
Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) has been one of the top performing stocks of 2012. Not just in emerging pharma and in biotech, but across the board. Now we have some more good news…
SciClone Pharmaceuticals Inc. (NASDAQ: SCLN) has filed to raise capital, some for the company and some for its existing shareholders. The filing with the SEC includes the sale of any combination of common stock,…
The average older American living independently does not have the means to meet basic standards of living, according to a report published by Wider Opportunities for Women (WOW) and the Gerontology Institute at the…
Many of the medical costs that Congress has begun to battle can be controlled. There is an argument this includes the cost of Medicare, Medicaid, drugs, doctor visits and preventable diseases. People who live lives…
The AARP put out a remarkably complex research paper that shows, among other things, that the costs that people over 50 paid for commonly used drugs rose 25.6% between 2005 and 2009. The data…
An organization called the International Federation of Health Plans keeps track of medical costs in most of the developed nations around the world. As would be expected, the costs for most procedures and medical treatment…
VIVUS, Inc. (NASDAQ: VVUS) is going to likely have a huge day on Thursday. The FDA panel reviewing its Qnexa drug to treat obesity has voted overwhelmingly to offer FDA panel backing in favor of recommending…
Gilead Sciences Inc. (NASDAQ: GILD) is being crushed after a disappointing result in its Hepatitis C treatment after reporting that a majority of hepatitis C genotype-1 patients who had a previous null response to…
Instead of admitting that it has, in the past, sold food with too much sodium, salt and sugar, Walmart (NYSE: WMT) has made a public relations bonanza of its decision to sell more healthy…
Merck & Company, Inc. (NYSE: MRK) is trading up after its earnings report. With a high dividend yield of 4.4%, many investors are watching this despite a stance of little to no real growth…